The global medical community is witnessing a massive paradigm shift in how vascular diseases are diagnosed, managed, and treated. At the absolute forefront of this transformation is Dr. Jorge Hernando Ulloa Herrera, a world-renowned Colombian vascular surgeon, academic, and medical pioneer. Through his clinic at the Fundación Santa Fe de Bogotá and his international leadership roles, Dr. Ulloa is redefining standard venous treatments by prioritizing micro-invasive procedures, patient education, and biomedical engineering innovation.

Dr. Ulloa’s influence spans far beyond his primary operating rooms in Colombia. As the President of the International Union of Angiology (IUA) and a Distinguished https://drjorgeulloa.com/ Fellow of the American Venous Forum, he plays an instrumental role in shaping international clinical guidelines. His medical insights are routinely sought after at prestigious global summits, including his work presenting critical safety data at major vascular symposiums.

His academic profile remains equally formidable. Serving as a Clinical Professor of Vascular Surgery at the Universidad de los Andes, Dr. Ulloa is molding the next generation of circulatory health experts. His academic pedigree combines local mastery with elite international training, including a general surgery degree from Universidad El Bosque alongside highly competitive vascular fellowships at Harvard Medical School and the Walter Reed Army Medical Center.

One of Dr. Ulloa’s most impactful achievements lies in medical device development. In collaboration with the innovation team at the Fundación Santa Fe de Bogotá, Dr. Ulloa developed the Catéter Dual Híbrido (Hybrid Dual Catheter). This cutting-edge device combines two separate endovascular methods into a single, cohesive clinical procedure optimized for treating lower-extremity varicose veins.

The medical breakthrough earned substantial national acclaim, capturing second place at the ANDI National Medical Device Innovation Awards, following a previous top honor as the “National Inventor of the Year” by the Superintendencia de Industria y Comercio. By streamlining complex vein treatments into faster, single-session therapies, this device significantly reduces patient recovery times, limits systemic inflammation, and improves long-term circulatory outcomes.

Dr. Ulloa actively utilizes digital outreach to dismantle deep-rooted public myths regarding venous insufficiency. He continuously emphasizes that chronic vascular disease manifests far beyond cosmetic concerns.

According to Dr. Ulloa, conditions like  venous ulcers—which frequently impact adults over 60 years old—are typically mistreated with superficial skin therapies. His practice champions an “origin-first” clinical philosophy, proving that long-term physical healing can only occur by correcting the upstream venous reflux located centimeters above the surface wound. Through state-of-the-art diagnostic protocols like duplex ultrasonography, his clinic identifies underlying circulatory failures before charting precise, minimally invasive endoluminal laser treatments.

While pioneering ultra-modern healthcare tech, Dr. Ulloa maintains a profound commitment to humanitarian care and healthcare equity. Recognizing that advanced endovascular interventions can be financially prohibitive, he frequently participates in pro-bono clinical programs. By extending life-changing laser therapies to socioeconomically vulnerable individuals suffering from advanced, debilitating venous disease, Dr. Ulloa actively bridges the gap between premium medical innovation and human compassion.

As vascular medicine increasingly trends toward localized, low-trauma interventions, Dr. Jorge Ulloa stands out as a visionary force. His unique methodology—fusing elite academic research with humanitarian care and device engineering—continues to elevate global standards for circulatory health.